Abstract

The cytochrome bc1 complex of the mitochondrial respiratory chain is a proven target for agricultural fungicides. The complex possesses two substrate/inhibitor binding pockets, termed Qo site and Qi site. Their inhibitors are classified as QoIs (Qo site binding inhibitors) and QiIs (Qi site binding inhibitors), with a few rare compounds targeting both sites. Several tools are available to determine the mode of action of bc1 complex inhibitors, which include spectroscopic methods and mutational analysis. Most of the agrifungicides bind at the Qo site of the complex. 338They share the same binding mode as the same resistance mutation in the Qo site, namely G143A, confers cross-resistance to these QoIs, with the exception of metyltetraprole, a new compound still in development. Until recently, only three agrifungicides targeting the Qi site were available. They are active only against oomycetes. By contrast, the newly marketed fenpicoxamid is active against a broad range of ascomycetes. Novel compounds that can counter the problem of the widespread resistance mutation G143A, such as metyltetraprole and fenpicoxamid, are likely to be useful tools for the control of pathogenic fungi. However, the possible occurrence of resistance mutations, especially target site mutations, remains an issue.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.